Aurora Cannabis (ACB)
Produces medical cannabis internationally while operating North American plant-propagation businesses.
$4.22
After hours−0.04 (−0.94%)
At close$4.26(+5.71%)
In millions of USD, except per-share figures · converted from CAD at the latest rate
| In millions | Q2 FY24Sep 2023 | Q3 FY24Dec 2023 | Q4 FY24Mar 2024 | Q1 FY25Jun 2024 | Q2 FY25Sep 2024 | Q3 FY25Dec 2024 | Q4 FY25Mar 2025 | Q1 FY26Jun 2025 | Q2 FY26Sep 2025 | Q3 FY26Dec 2025 | Q4 FY26Mar 2026 | Q1 FY27Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 45 | 46 | 48 | 59 | 58 | 63 | 64 | 63 | 64 | 67 | 27 | 48 |
| Cost of revenue | 20 | 28 | 12 | 28 | 28 | 7 | 49 | 7 | 41 | 34 | 14 | 51 |
| Gross profit | 24 | 18 | 36 | 32 | 30 | 56 | 16 | 56 | 23 | 33 | 13 | −3 |
| 32 | 30 | 34 | 31 | 32 | 30 | 37 | 30 | 36 | 30 | 31 | 31 | |
| Research & development | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| 28 | 26 | 31 | 28 | 29 | 27 | 34 | 27 | 33 | 28 | 30 | 29 | |
| Selling & marketing | 9 | 9 | 10 | 10 | 10 | 9 | 11 | 9 | 10 | 11 | 12 | 0 |
| General & administrative | 19 | 18 | 20 | 18 | 19 | 18 | 23 | 18 | 23 | 18 | 18 | 0 |
| Other expenses | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 1 | 0 |
| Operating income | −8 | −13 | 2 | 1 | −2 | 26 | −22 | 26 | −13 | 3 | — | −34 |
| 8 | 0 | −12 | 5 | 2 | −3 | 7 | −3 | −20 | −5 | 26 | 31 | |
| Interest income | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Interest expense | 3 | 2 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 0 | 0 |
| Other non-operating income | −11 | −2 | 11 | −6 | −4 | 2 | −9 | 2 | 19 | 2 | −33 | 0 |
| Income before tax | 0 | −12 | −10 | 5 | 0 | 23 | −14 | 23 | −33 | −1 | 8 | −3 |
| Income tax expense | 0 | 0 | −1 | 2 | −1 | 1 | 1 | 1 | 4 | 0 | −3 | 0 |
| Net income from continuing operations | 0 | −12 | −9 | 3 | 1 | 22 | −16 | 22 | −38 | −1 | 11 | −3 |
| Discontinued operations | −2 | −1 | 0 | 0 | −10 | 0 | 0 | 0 | 0 | 0 | −52 | 0 |
| Other adjustments | — | — | −3 | 0 | 0 | 0 | −2 | 0 | 0 | 0 | 0 | 0 |
| Net income | 0 | −12 | −12 | 5 | −9 | 23 | −17 | 23 | −37 | 1 | −41 | −3 |
| EPS, basic | −$0.01 | −$0.37 | −$0.18 | $0.09 | −$0.16 | $0.41 | −$0.32 | $0.41 | −$0.65 | $0.02 | −$0.70 | −$0.05 |
| EPS, diluted | −$0.01 | −$0.37 | −$0.18 | $0.09 | −$0.16 | $0.41 | −$0.31 | $0.41 | −$0.65 | $0.02 | −$0.70 | −$0.05 |
| Weighted average shares, basic | 38 | 47 | 52 | 52 | 55 | 55 | 55 | 55 | 55 | 57 | 57 | 62 |
| Weighted average shares, diluted | 38 | 47 | 52 | 52 | 56 | 56 | 56 | 56 | 56 | 57 | 57 | 62 |
| EBITDA | 9 | −5 | −4 | 11 | 6 | 28 | −8 | 28 | −27 | 6 | 5 | −31 |
| Depreciation & amortization | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | −10 | 3 |
| EBIT | 3 | −10 | −9 | 7 | 2 | 24 | −12 | 24 | −32 | 2 | 15 | −34 |